4//SEC Filing
Naeve Gregory S. 4
Accession 0001209191-17-050005
CIK 0001358403other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 6:46 PM ET
Size
7.4 KB
Accession
0001209191-17-050005
Insider Transaction Report
Form 4
Naeve Gregory S.
Sr. VP, Chief Business Officer
Transactions
- Award
Common Stock
2017-08-21+15,000→ 15,000 total - Award
Employee Stock Option (right to buy)
2017-08-21+130,000→ 130,000 totalExercise: $7.63Exp: 2027-08-20→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that vest in four equal annual installments on each of the one, two, three and four year anniversaries of August 21, 2017.
- [F2]25% of the shares subject to the stock option vest and become exercisable on August 21, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001714833
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 6:46 PM ET
- Size
- 7.4 KB